BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19157668)

  • 1. Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients.
    Lima V; Fernandes K; Rachlis B; Druyts E; Montaner J; Hogg R
    Soc Sci Med; 2009 Mar; 68(6):1044-9. PubMed ID: 19157668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.
    Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S
    Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease progression in HIV-1 infected children and adolescents--results of a German-Austrian cohort study.
    Funk MB; Buchholz B; Notheis G; Neubert J; Feiterna-Sperling C; Ganschow R; Simon T; Hornemann F; Peters AM; Rütschle H; Horneff G; Lechner E; Hanschmann KM; Wintergerst U;
    Eur J Med Res; 2008 Aug; 13(8):371-8. PubMed ID: 18952519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS.
    Garvie PA; Lensing S; Rai SN
    Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
    Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
    Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality is influenced by locality in a major HIV/AIDS epidemic.
    Druyts EF; Rachlis BS; Lima VD; Harvard SS; Zhang W; Brandson EK; Strathdee SA; Montaner JS; Hogg RS
    HIV Med; 2009 May; 10(5):274-81. PubMed ID: 19210694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
    Ruanjahn G; Roberts D; Monterosso L
    AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral medication errors among hospitalized patients with HIV infection.
    Rastegar DA; Knight AM; Monolakis JS
    Clin Infect Dis; 2006 Oct; 43(7):933-8. PubMed ID: 16941379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill.
    Delgado J; Heath KV; Yip B; Marion S; Alfonso V; Montaner JS; O'Shaughnessy MV; Hogg RS
    Antivir Ther; 2003 Oct; 8(5):471-8. PubMed ID: 14640395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and benefits of HAART for patients with HIV in a public hospital in Mexico.
    Aracena-Genao B; Navarro JO; Lamadrid-Figueroa H; Forsythe S; Trejo-Valdivia B
    AIDS; 2008 Jul; 22 Suppl 1():S141-8. PubMed ID: 18664946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telephone nurse counseling improves HIV medication adherence: an effectiveness study.
    Cook PF; McCabe MM; Emiliozzi S; Pointer L
    J Assoc Nurses AIDS Care; 2009; 20(4):316-25. PubMed ID: 19576548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between religion and HAART adherence in pediatric HIV patients.
    Park J; Nachman S
    AIDS Care; 2010 May; 22(5):556-61. PubMed ID: 20397076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.
    Engsig FN; Omland LH; Larsen MV; Rasmussen LD; Qvist T; Gerstoft J; Obel N
    HIV Med; 2010 Aug; 11(7):457-61. PubMed ID: 20158527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study.
    Conen A; Fehr J; Glass TR; Furrer H; Weber R; Vernazza P; Hirschel B; Cavassini M; Bernasconi E; Bucher HC; Battegay M;
    Antivir Ther; 2009; 14(3):349-57. PubMed ID: 19474469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.
    Wood E; Kerr T; Palepu A; Zhang R; Strathdee SA; Tyndall MW; Montaner JS; Hogg RS
    J Infect; 2006 Apr; 52(4):233-6. PubMed ID: 16169594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.